PepGen (PEPG) Competitors $1.48 +0.13 (+9.63%) Closing price 04:00 PM EasternExtended Trading$1.53 +0.05 (+3.38%) As of 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PEPG vs. VTYX, MDWD, FTLF, CRBU, BTMD, ACTU, BIOA, TVGN, KYTX, and NVCTShould you be buying PepGen stock or one of its competitors? The main competitors of PepGen include Ventyx Biosciences (VTYX), MediWound (MDWD), FitLife Brands (FTLF), Caribou Biosciences (CRBU), biote (BTMD), Actuate Therapeutics (ACTU), BioAge Labs (BIOA), Tevogen Bio (TVGN), Kyverna Therapeutics (KYTX), and Nuvectis Pharma (NVCT). These companies are all part of the "pharmaceutical products" industry. PepGen vs. Its Competitors Ventyx Biosciences MediWound FitLife Brands Caribou Biosciences biote Actuate Therapeutics BioAge Labs Tevogen Bio Kyverna Therapeutics Nuvectis Pharma PepGen (NASDAQ:PEPG) and Ventyx Biosciences (NASDAQ:VTYX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership. Is PEPG or VTYX more profitable? Ventyx Biosciences' return on equity of -48.89% beat PepGen's return on equity.Company Net Margins Return on Equity Return on Assets PepGenN/A -92.51% -70.39% Ventyx Biosciences N/A -48.89%-44.87% Do analysts recommend PEPG or VTYX? PepGen currently has a consensus price target of $7.25, indicating a potential upside of 389.86%. Ventyx Biosciences has a consensus price target of $7.50, indicating a potential upside of 226.09%. Given PepGen's higher probable upside, research analysts clearly believe PepGen is more favorable than Ventyx Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PepGen 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Ventyx Biosciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders & institutionals have more ownership in PEPG or VTYX? 58.0% of PepGen shares are owned by institutional investors. Comparatively, 97.9% of Ventyx Biosciences shares are owned by institutional investors. 5.2% of PepGen shares are owned by company insiders. Comparatively, 14.5% of Ventyx Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to PEPG or VTYX? In the previous week, PepGen had 2 more articles in the media than Ventyx Biosciences. MarketBeat recorded 5 mentions for PepGen and 3 mentions for Ventyx Biosciences. Ventyx Biosciences' average media sentiment score of 1.73 beat PepGen's score of 0.58 indicating that Ventyx Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PepGen 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ventyx Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk and volatility, PEPG or VTYX? PepGen has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Ventyx Biosciences has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Which has preferable earnings and valuation, PEPG or VTYX? Ventyx Biosciences is trading at a lower price-to-earnings ratio than PepGen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPepGenN/AN/A-$89.98M-$2.96-0.50Ventyx BiosciencesN/AN/A-$135.12M-$1.68-1.37 SummaryPepGen and Ventyx Biosciences tied by winning 6 of the 12 factors compared between the two stocks. Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PEPG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PEPG vs. The Competition Export to ExcelMetricPepGenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$44.28M$3.20B$5.86B$10.15BDividend YieldN/A2.30%5.68%4.59%P/E Ratio-0.5021.1774.5225.93Price / SalesN/A473.02539.62123.65Price / CashN/A46.6837.5660.44Price / Book0.419.6112.166.29Net Income-$89.98M-$53.29M$3.28B$270.77M7 Day Performance5.71%0.29%0.98%3.36%1 Month Performance29.82%8.91%7.20%6.41%1 Year Performance-83.65%13.14%63.06%28.26% PepGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PEPGPepGen2.8258 of 5 stars$1.48+9.6%$7.25+389.9%-85.0%$44.28MN/A-0.5030Analyst ForecastGap UpVTYXVentyx Biosciences2.6888 of 5 stars$2.38-5.6%$7.50+215.1%+13.3%$179.70MN/A-1.4230Positive NewsMDWDMediWound1.6253 of 5 stars$16.74+2.8%$32.25+92.7%+11.4%$176.06M$19.86M-6.3480Gap UpFTLFFitLife Brands4.3359 of 5 stars$19.13+2.1%$23.00+20.2%+8.6%$175.90M$64.47M22.7720Positive NewsCRBUCaribou Biosciences2.6122 of 5 stars$1.81-3.2%$6.67+268.3%-6.4%$174.14M$9.99M-1.02100Positive NewsBTMDbiote3.0315 of 5 stars$3.45-0.3%$6.00+73.9%-43.6%$171.06M$197.19M3.83194Positive NewsACTUActuate Therapeutics2.5513 of 5 stars$7.94-3.6%$20.33+156.1%-13.9%$170.94MN/A0.0010BIOABioAge Labs0.1972 of 5 stars$5.09+6.9%N/AN/A$170.65MN/A0.00N/APositive NewsTVGNTevogen Bio3.8973 of 5 stars$0.88+1.5%$10.00+1,037.4%+101.3%$170.43MN/A0.003High Trading VolumeKYTXKyverna Therapeutics3.3317 of 5 stars$3.90-1.0%$16.60+325.6%-40.6%$170.39M$7.03M-1.0696Positive NewsNVCTNuvectis Pharma3.4703 of 5 stars$6.40-4.2%$15.33+139.6%+1.1%$170.05MN/A-5.478Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Ventyx Biosciences Alternatives MediWound Alternatives FitLife Brands Alternatives Caribou Biosciences Alternatives biote Alternatives Actuate Therapeutics Alternatives BioAge Labs Alternatives Tevogen Bio Alternatives Kyverna Therapeutics Alternatives Nuvectis Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PEPG) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredCollect Your $21K — Courtesy of Donald Trump 🇺🇸A small group of early investors have found a way to start collecting payouts as high as $21,307 — before the ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PEPG Stock Alerts